ArticleCancer medicine2017

Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.

Tino F Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.